These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37509709)

  • 1. Biomarkers of the Complement System Activation (C3a, C5a, sC5b-9) in Serum of Patients before and after Liver Transplantation.
    Budkowska M; Ostrycharz E; Serwin NM; Nazarewski Ł; Cecerska-Heryć E; Poręcka M; Rykowski P; Pietrzak R; Zieniewicz K; Siennicka A; Hukowska-Szematowicz B; Dołęgowska B
    Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration of complement split products in plasma and urine as biomarkers of kidney graft rejection.
    Gramkow AM; Isaksson GL; Palarasah Y; Jensen BL; Alnor A; Thiesson HC
    Immunobiology; 2023 Jul; 228(4):152462. PubMed ID: 37406469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement activation in cancer patients undergoing immunotherapy with interleukin-2 (IL-2): binding of complement and C-reactive protein by IL-2-activated lymphocytes.
    Vachino G; Gelfand JA; Atkins MB; Tamerius JD; Demchak P; Mier JW
    Blood; 1991 Nov; 78(10):2505-13. PubMed ID: 1824247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase of C3a is Associated with Hemorrhagic Propensity in Patients with Immune Thrombocytopenia.
    Ge J; Wang L; Li J; Hu Y; Xu Q; Chen Y; Hou R; Ruan M; Xia R; Zeng Q
    Clin Lab; 2017 Apr; 63(4):765-771. PubMed ID: 28397467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel multiplex detection array revealed systemic complement activation in oral squamous cell carcinoma.
    Gallenkamp J; Spanier G; Wörle E; Englbrecht M; Kirschfink M; Greslechner R; Braun R; Schäfer N; Bauer RJ; Pauly D
    Oncotarget; 2018 Jan; 9(3):3001-3013. PubMed ID: 29423024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastro-intestinal complement activation during human liver transplantation: impact on postoperative liver function.
    Rønholm E; Tomasdottir H; Runeborg J; Mattsby-Baltzer I; Olausson3 M; Aneman A; Bengtsson A
    Acta Anaesthesiol Scand; 2000 Aug; 44(7):850-7. PubMed ID: 10939698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement activation during liver transplantation.
    Tomasdottir H; Henriksson BA; Bengtson JP; Bengtsson A; Stenqvist O; Persson H
    Transplantation; 1993 Apr; 55(4):799-802. PubMed ID: 8475554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring Circulating Complement Activation Products in Myeloperoxidase- and Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Wu EY; McInnis EA; Boyer-Suavet S; Mendoza CE; Aybar LT; Kennedy KB; Poulton CJ; Henderson CD; Hu Y; Hogan SL; Hu P; Xiao H; Nachman PH; Jennette JC; Falk RJ; Bunch DO
    Arthritis Rheumatol; 2019 Nov; 71(11):1894-1903. PubMed ID: 31215772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma C3a and C4a levels in liver transplant recipients: a longitudinal study.
    Pfeifer PH; Brems JJ; Brunson M; Hugli TE
    Immunopharmacology; 2000 Feb; 46(2):163-74. PubMed ID: 10647874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of complement activation fragments C3a and sC5b-9 for development of severe disease in patients with acute pancreatitis.
    Gloor B; Stahel PF; Müller CA; Schmidt OI; Büchler MW; Uhl W
    Scand J Gastroenterol; 2003 Oct; 38(10):1078-82. PubMed ID: 14621284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement factors C3a and C5a mimick a proinflammatory microenvironment and increase HBV IGRA sensitivity.
    Bröker K; Terzenbach R; Bentzien F; Lüth S; Dammermann W
    J Transl Med; 2019 Jan; 17(1):6. PubMed ID: 30602374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement system activation during orthotopic liver transplantation in man. Indications of peroperative complement system activation in the gut.
    Rønholm E; Tomasdottir H; Runeborg J; Bengtsson A; Bengtson JP; Stenqvist O; Friman S
    Transplantation; 1994 Jun; 57(11):1594-7. PubMed ID: 8009593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Removal of activated complement from shed blood: comparison of high- and low-dilutional haemofiltration.
    Arnestad JP; Hyllner M; Bengtson JP; Tylman M; Mollnes TE; Bengtsson A
    Acta Anaesthesiol Scand; 1998 Aug; 42(7):811-5. PubMed ID: 9698958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of dicarbonyl stress with complement activation: the CODAM study.
    Xin Y; Hertle E; van der Kallen CJH; Schalkwijk CG; Stehouwer CDA; van Greevenbroek MMJ
    Diabetologia; 2020 May; 63(5):1032-1042. PubMed ID: 31993713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in plasma complement levels after human ischemic stroke.
    Mocco J; Wilson DA; Komotar RJ; Sughrue ME; Coates K; Sacco RL; Elkind MS; Connolly ES
    Neurosurgery; 2006 Jul; 59(1):28-33; discussion 28-33. PubMed ID: 16823297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of complement activation in the isolated heart. Role of the terminal complement components.
    Homeister JW; Satoh P; Lucchesi BR
    Circ Res; 1992 Aug; 71(2):303-19. PubMed ID: 1628389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
    Langone JJ; Das C; Bennett D; Terman DS
    J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaphylatoxins in organ transplantation.
    Li K; Zhou W
    Semin Immunol; 2013 Feb; 25(1):20-8. PubMed ID: 23722015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement Components sC5b-9 and CH50 Predict Prognosis in Heart Failure Patients Combined With Hypertension.
    Wang W; Cai D
    Am J Hypertens; 2020 Jan; 33(1):53-60. PubMed ID: 31429866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary Properdin and sC5b-9 Are Independently Associated With Increased Risk for Graft Failure in Renal Transplant Recipients.
    Lammerts RGM; Eisenga MF; Alyami M; Daha MR; Seelen MA; Pol RA; van den Born J; Sanders JS; Bakker SJL; Berger SP
    Front Immunol; 2019; 10():2511. PubMed ID: 31736953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.